Showing 261 - 280 results of 5,484 for search '"Pharmaceutics"', query time: 0.06s Refine Results
  1. 261
  2. 262

    Fabrication of promising competitive graphene nanocomposite transducer to determine Prucalopride succinate in pharmaceutical formulation and in spiked human biological fluids by Marwa T. Saad, Shereen A. Boltia, Taghreed A. Fattah, Hala E. Zaazaa

    Published 2025-01-01
    “…This innovative approach holds great potential for applications in pharmaceutical analysis and quality control, providing a more sustainable and efficient method for the analysis of prucalopride succinate.…”
    Get full text
    Article
  3. 263
  4. 264

    Application of Factorial and Doehlert Designs for the Optimization of the Simultaneous Separation and Determination of Antimigraine Drugs in Pharmaceutical Formulations by RP-HPLC-UV by Sami Jebali, Chaouki Belgacem, Mohamed Radhouen Louhaichi, Senda Bahri, Latifa Latrous El Atarche

    Published 2019-01-01
    “…A sensitive, precise, accurate, and specific isocratic reversed-phase high-performance liquid chromatographic (RP-HPLC) method for the simultaneous separation and determination of zolmitriptan, naratriptan, dihydroergotamine, ketotifen, and pizotifen in pharmaceutical formulations has been developed and validated. …”
    Get full text
    Article
  5. 265
  6. 266
  7. 267

    Spectrophotometric Determination of Zidovudine in Pharmaceuticals Based on Charge-Transfer Complexation Involving N-Bromosuccinimide, Metol and Sulphanilic Acid as Reagents by K. Basavaiah, U. R. Anil Kumar

    Published 2007-01-01
    “…A simple spectrophotometric method is proposed for the determination of zidovudine(ZDV) in bulk drug and in pharmaceutical preparations. The method is based on the oxidation of ZDV by a known excess of oxidant N-bromosuccinimide (NBS), in buffer medium of pH 1.5, followed by the estimation of unreacted amount of oxidant with metol and sulphanilic acid. …”
    Get full text
    Article
  8. 268
  9. 269
  10. 270

    Recent progress in pharmaceutical excipients as P-glycoprotein inhibitors for potential improvement of oral drug bioavailability: A comprehensive overview by Fitrianti Darusman, Taofik Rusdiana, Iyan Sopyan, Hanifa Rahma, Millati Hanifa

    Published 2025-02-01
    “…Pharmaceutical excipients such as P-glycoprotein inhibitors can also increase the solubility and affinity of drugs to the intestinal membrane, enhance paracellular pathways and endocyte uptake, and activate lymph transport pathways, thereby increasing the bioavailability of oral drugs. …”
    Get full text
    Article
  11. 271

    Ukrainian Patients’ Perspectives on Advanced Pharmaceutical Services Provided by Polish Pharmacists: A Cross-Border Support Initiative by Merks P, Religioni U, Borowska M, Hechman R, Konstanty M, Kaźmierczak J, Chełstowska B, Vaillancourt R, Drab A, Wdowiak K

    Published 2025-01-01
    “…The survey was distributed after pharmaceutical consultations in one of the cities near the Polish-Ukrainian border. …”
    Get full text
    Article
  12. 272
  13. 273
  14. 274

    Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016) by Piotr Ozieranski, Emily Rickard, Shai Mulinari, Marcell Csanádi

    Published 2020-09-01
    “…Objectives To examine the under-reporting of pharmaceutical company payments to patient organisations by donors and recipients.Design Comparative descriptive analysis of payments disclosed on drug company and charity regulator websites.Setting UK.Participants 87 donors (drug companies) and 425 recipients (patient organisations) reporting payments in 2012–2016.Main outcome measures Number and value of payments reported by donors and recipients; differences in reported payments from/to the same donors and recipients; payments reported in either dataset but not the other one; agreement between donor–recipient ties established by payments; overlap between donor and recipient lists and, respectively, industry and patient organisation data.Results Of 87 donors, 63 (72.4%) reported payments but 84 (96.6%) were mentioned by recipients. …”
    Get full text
    Article
  15. 275
  16. 276

    Development and Validation of an Ion-Pair HPLC-UV Method for the Quantitation of Quinoline and Indoloquinoline Alkaloids in Herbal and Pharmaceutical Antimalarial Formulations by Samuel Oppong Bekoe, Emmanuel Orman, Samuel Awenteka Adjabui, Abena Amponsaa Brobbey, James Oppong-Kyekyeku, Kwabena Frimpong-Manso Opuni, Noble Kuntworbe, Samuel Asare-Nkansah

    Published 2022-01-01
    “…An HPLC method targeting quinoline and indoloquinoline antimalarial alkaloids was developed, validated, and applied to evaluate herbal and pharmaceutical antimalarial formulations (HPAFs) and starting materials (APIs). …”
    Get full text
    Article
  17. 277
  18. 278
  19. 279

    Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016 by Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb

    Published 2020-09-01
    “…Objective To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex.Design and participants Cohort study of all German HCPs who voluntarily agreed that at least one payment they received in 2015 and 2016 from pharmaceutical companies is disclosed.Main outcome measures Number of HCPs who disclosed at least one payment in the database; separated by year of disclosure and whether they disclosed once or repeatedly. …”
    Get full text
    Article
  20. 280